Publications by authors named "Peter Lichtlen"

Claim this Profile
A
A Bispecific, Tetravalent Antibody Targeting Inflammatory and Pruritogenic Pathways in Atopic Dermatitis.
Julia Tietz, Tea Gunde, Stefan Warmuth, Christopher Weinert, Matthias Brock, Peter Lichtlen

JID Innov· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An engineered T-cell engager with selectivity for high mesothelin-expressing cells and activity in the presence of soluble mesothelin.
Daniel Snell, Tea Gunde, Stefan Warmuth, Bithi Chatterjee, Matthias Brock, Peter Lichtlen

Oncoimmunology· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering of a trispecific tumor-targeted immunotherapy incorporating 4-1BB co-stimulation and PD-L1 blockade.
Stefan Warmuth, Tea Gunde, Daniel Snell, Matthias Brock, Christopher Weinert, Peter Lichtlen

Oncoimmunology· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lubiprostone for Pediatric Functional Constipation: Randomized, Controlled, Double-Blind Study With Long-term Extension.
Marc A Benninga, Sunny Z Hussain, Manu R Sood, Samuel Nurko, Paul Hyman, Peter Lichtlen

Clin Gastroenterol Hepatol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Lubiprostone, an Intestinal Secretagogue, on Electrolyte Homeostasis in Chronic Idiopathic and Opioid-induced Constipation.
Satish S C Rao, Peter Lichtlen, Sepideh Habibi

J Clin Gastroenterol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation.
Atoya Adams, Charles Barish, Angel Chen, Patrick Dennis, Richard Krause, Peter Lichtlen

Adv Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation.
Atoya Adams, Charles Barish, Angel Chen, Patrick Dennis, Richard Krause, Peter Lichtlen

Adv Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet Needs in Pediatric Functional Constipation.
Manu Sood, Peter Lichtlen, Maria Claudia Perez

Clin Pediatr (Phila)· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation.
Becky Pennington, Emily-Ruth Marriott, Peter Lichtlen, Ayesha Akbar, Anthony J Hatswell

Pharmacoecon Open· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
Lynn R Webster, Randall P Brewer, Peter Lichtlen, Taryn Losch-Beridon, Shadreck Mareya

Pain Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Penetration of a topically administered anti-tumor necrosis factor alpha antibody fragment into the anterior chamber of the human eye.
Michael A Thiel, Andreas Wild, Martin K Schmid, Oliver Job, Frank Bochmann, Peter Lichtlen

Ophthalmology· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative contribution of VEGF and TNF-alpha in the cynomolgus laser-induced CNV model: comparing the efficacy of bevacizumab, adalimumab, and ESBA105.
Peter Lichtlen, Tim T Lam, T Michael Nork, Tim Streit, David M Urech

Invest Ophthalmol Vis Sci· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
Esther Furrer, Marianne Berdugo, Cinzia Stella, Francine Behar-Cohen, Robert Gurny, Peter Lichtlen

Invest Ophthalmol Vis Sci· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.
Michael Ottiger, Michael A Thiel, Ulrich Feige, Peter Lichtlen, David M Urech

Invest Ophthalmol Vis Sci· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools.
Peter Lichtlen, M Hasan Mohajeri

J Neurochem· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of metal transcription factor-1 suppresses tumor growth through enhanced matrix deposition.
Zishan A Haroon, Khalid Amin, Peter Lichtlen, Barbara Sato, Nhung T Huynh

FASEB J· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metal-responsive transcription factor-1 (MTF-1) is essential for embryonic liver development and heavy metal detoxification in the adult liver.
Ying Wang, Ursula Wimmer, Peter Lichtlen, Daniel Inderbitzin, Bruno Stieger

FASEB J· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell growth selection system to detect extracellular and transmembrane protein interactions.
David M Urech, Peter Lichtlen, Alcide Barberis

Biochim Biophys Acta· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis